Entry
Name
Atebimetinib (USAN/INN)
Formula
C23H27FN4O6S
Exact mass
506.1635
Mol weight
506.55
Structure
Mol file KCF file DB search
Class
Antineoplastic
DG03137 MEK inhibitor
Efficacy
Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor
Comment
Treatment of solid tumors
Target
Pathway
Brite
Drug groups [BR:br08330 ]
Antineoplastic
DG03137 MEK inhibitor
D13350 Atebimetinib
Target-based classification of drugs [BR:br08310 ]
Protein kinases
Serine/threonine kinases
STE group
MAP2K (MEK)
D13350 Atebimetinib (USAN/INN)
Other DBs
LinkDB
All DBs
KCF data
Show ATOM 35
1 C8y C 16.2400 -27.7200
2 C8y C 16.2400 -29.1200
3 C8y C 17.4524 -29.8200
4 C8y C 18.6649 -29.1200
5 C8y C 18.6649 -27.7200
6 O7x O 17.4524 -27.0200
7 C8x C 15.0276 -27.0200
8 C8y C 13.8151 -27.7200
9 C8x C 13.8151 -29.1200
10 C8x C 15.0276 -29.8200
11 O7a O 12.5840 -27.0090
12 C7a C 11.3788 -27.7047
13 O6a O 10.1965 -27.0219
14 N1c N 11.3784 -29.1196
15 C1a C 10.1895 -29.8059
16 C1a C 12.6143 -29.8339
17 C1b C 17.4524 -31.2198
18 N1c N 16.2232 -31.9297
19 C1a C 15.0192 -31.2346
20 C1a C 16.2234 -33.3199
21 O6a O 19.8960 -27.0090
22 C1b C 19.8960 -29.8310
23 C8y C 21.1012 -29.1353
24 C8y C 22.2835 -29.8181
25 C8y C 23.4960 -29.1183
26 C8x C 23.4962 -27.7183
27 C8x C 22.3138 -27.0355
28 C8x C 21.1013 -27.7353
29 N1b N 24.7270 -29.8293
30 S4a S 25.9307 -29.1346
31 N1b N 27.1137 -29.8178
32 C1a C 28.3074 -29.1287
33 X F 22.2834 -31.2198
34 O3c O 25.2307 -27.9221
35 O3c O 26.6307 -27.9221
BOND 37
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 1
7 1 7 2
8 7 8 1
9 8 9 2
10 9 10 1
11 2 10 2
12 8 11 1
13 11 12 1
14 12 13 2
15 12 14 1
16 14 15 1
17 14 16 1
18 3 17 1
19 17 18 1
20 18 19 1
21 18 20 1
22 5 21 2
23 4 22 1
24 22 23 1
25 23 24 2
26 24 25 1
27 25 26 2
28 26 27 1
29 27 28 2
30 23 28 1
31 25 29 1
32 29 30 1
33 30 31 1
34 31 32 1
35 24 33 1
36 30 34 2
37 30 35 2